Literature DB >> 3262735

C-reactive protein in early detection of bacteremic versus viral infections in immunocompetent and compromised children.

H Peltola1, M Jaakkola.   

Abstract

The value of quantitatively determined C-reactive protein (CRP), measured from a finger prick sample for rapid detection of septicemia, was examined in 76 blood culture-positive infections in 54 immunocompetent and 18 compromised children; 73 patients with systemic viral infections served as controls. Development of a positive CRP reaction was also studied in 40 cases of acute epiglottitis. Beyond the neonatal age, an increased CRP value (greater than or equal to 20 mg/L) was found in 60 of 64 (94%) children with a positive blood culture for bacteria or fungus. By contrast, CRP remained below this value in 56 of 73 (77%) with viral infections. The immunologic status did not influence the CRP response. However, time had a highly significant (p less than 0.001) effect on CRP; a history of 6 to 12 hours of illness was required before CRP increased above normal. We conclude that CRP is a sensitive and rapidly reacting index in bacteremic infections. However, because other factors than septicemia also increase CRP, we deem a negative CRP value most informative; if two determinations taken several hours apart are less than 20 mg/L, the patient is very unlikely to have invasive bacterial infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262735     DOI: 10.1016/s0022-3476(88)80372-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  23 in total

Review 1.  How useful is C-reactive protein in detecting occult bacterial infection in young children with fever without apparent focus?

Authors:  Nitin Maheshwari
Journal:  Arch Dis Child       Date:  2006-06       Impact factor: 3.791

2.  A new side effect of inhaled nitric oxide in neonates and infants with pulmonary hypertension: functional impairment of the neutrophil respiratory burst.

Authors:  P Gessler; T Nebe; A Birle; W Mueller; W Kachel
Journal:  Intensive Care Med       Date:  1996-03       Impact factor: 17.440

3.  Invasive fungal infection in Chinese patients with systemic lupus erythematosus.

Authors:  Guang-liang Chen; Yi Chen; Chang-qing Zhu; Cheng-de Yang; Shuang Ye
Journal:  Clin Rheumatol       Date:  2012-04-04       Impact factor: 2.980

4.  C-reactive protein in the management of children with fever after allogeneic bone marrow transplantation.

Authors:  C de Bel; E Gerritsen; G de Maaker; A Moolenaar; J Vossen
Journal:  Infection       Date:  1991 Mar-Apr       Impact factor: 3.553

Review 5.  Aetiology and management of children with acute fever of unknown origin.

Authors:  G O Akpede; G I Akenzua
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 6.  Early-onset neonatal sepsis.

Authors:  Kari A Simonsen; Ann L Anderson-Berry; Shirley F Delair; H Dele Davies
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

7.  Procalcitonin in children admitted to hospital with community acquired pneumonia.

Authors:  F Moulin; J Raymond; M Lorrot; E Marc; J Coste; J L Iniguez; G Kalifa; C Bohuon; D Gendrel
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

8.  The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever.

Authors:  E Littlejohn; W Marder; E Lewis; S Francis; J Jackish; W J McCune; E C Somers
Journal:  Lupus       Date:  2018-03-16       Impact factor: 2.911

9.  Sensitivity of erythrocyte sedimentation rate and C-reactive protein in childhood bone and joint infections.

Authors:  Markus Pääkkönen; Markku J T Kallio; Pentti E Kallio; Heikki Peltola
Journal:  Clin Orthop Relat Res       Date:  2009-06-17       Impact factor: 4.176

10.  Relation between cytokines and routine laboratory data in children with septic shock and purpura.

Authors:  J A Hazelzet; E van der Voort; J Lindemans; P G ter Heerdt; H J Neijens
Journal:  Intensive Care Med       Date:  1994-05       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.